Tesamorelin
Synthetic Growth Hormone Releasing Hormone
44 Amino Acids · MW: 5,135.9 Da
Amino Acids
44
Molecular Weight
5,135.9 Da
Half-life
~26-38 minutes
Research Score
4.7
Studies
234
Storage
N/A
What is Tesamorelin?
Tesamorelin is an FDA-approved synthetic analog of growth hormone-releasing hormone (GHRH). Approved as Egrifta for HIV-associated lipodystrophy, it reduces visceral adipose tissue while maintaining peripheral fat and improving body composition. Produces physiological GH release.
Key Benefits & Mechanisms
FDA-approved for lipodystrophy
Reduces visceral abdominal fat
Physiological GH release pattern
Improved body composition
Cognitive benefits (studied in aging)
Does not suppress natural GH axis
Improved IGF-1 levels
Research Summary
Tesamorelin has robust Phase III clinical evidence. FDA-approved in 2010. Multiple large-scale trials demonstrate significant reduction in trunk fat. Also being studied for cognitive decline in aging populations.
Related Peptides
Semaglutide
GLP-1 Receptor Agonist
Semaglutide is a GLP-1 receptor agonist with proven efficacy for weight management and glycemic control. FDA-approved as Ozempic (diabetes) and Wegovy (weight management), it mimics the incretin hormone GLP-1 to regulate appetite and blood sugar.
MetabolicTirzepatide
GIP/GLP-1 Dual Receptor Agonist
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. FDA-approved as Mounjaro (diabetes) and Zepbound (weight management). It offers superior weight loss compared to GLP-1-only agonists by targeting two incretin pathways simultaneously.
MetabolicIpamorelin
Growth Hormone Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GHRPs available.
PerformanceAOD-9604
Anti-Obesity Drug (Modified GH Fragment)
AOD-9604 is a modified fragment of human growth hormone (HGH fragment 177-191) specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or tissue growth, making it a targeted fat-loss peptide without typical GH side effects.
Metabolic